Ipsen Reaches Deal To Advance Precision T Cell Engagers From Marengo’s Tri-STAR Platform

(RTTNews) – Ipsen (IPSEY) and Marengo Therapeutics Inc. have expanded their ongoing oncology research partnership, to include TriSTAR, Marengo’s next-generation, precision T cell engager or TCE technology.

admin